Coronavirus (COVID-19) Q&A - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Coronavirus (COVID-19) Q&A — Health & Fitness
Coronavirus (COVID-19) Q&A

Conversations with experts and frontline clinicians about the COVID-19 pandemic, hosted by editors from the JAMA Network.

Latest Episodes:

Asymptomatic SARS-CoV-2 Transmission; Association of ICU Volume with Patient Mortality During the COVID-19 Pandemic Jan 19, 2021

Show notes

Editor in Chief Fred Rivara and Deputy Editor Steve Fihn discuss research published in JAMA Network Open in January 2021

Related Article:

Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Intensive Care Unit Strain and Mortality Risk Among Critically Ill Patients With COVID-19—There Is No "Me" in COVID

The Winter COVID-19 Surge in New York and Los Angeles Jan 15, 2021

Show notes

Mitchell Katz, MD, president and chief executive officer of New York City Health + Hospitals, and former Los Angeles County health agency director, discusses causes, similarities, and differences between the spike of COVID-19 cases, hospitalizations, and deaths in the 2 cities.

Related Article:

Modernize Medical Licensing, and Credentialing, Too—Lessons From the COVID-19 Pandemic

Coronavirus Critical Care Update With Lennie Derde and Christopher Seymour Jan 15, 2021

Show notes

The COVID-19 pandemic has prompted scientists to use adaptive research designs to evaluate potential treatments simultaneously and efficiently, increasing the likelihood that patients will receive treatments most likely to be effective for them. Lennie Derde, MD, of University Medical Center Utrecht in the Netherlands and JAMA Associate Editor Christopher W. Seymour, MD, of University of Pittsburgh Medical Center join JAMA's Q&A series to discuss the latest in critical care management of COVID-19 patients and emerging treatment strategies and therapies. Recorded January 13, 2021.

Related Article(s):

Sensible Medicine-Optimizing the Trade-off Between Learning and Doing in a Pandemic

An Opportune Time to Update Medical Licensing Jan 13, 2021

Show notes

Interview with Samyukta Mullangi, MD, MBA, author of The COVID-19 Pandemic—An Opportune Time to Update Medical Licensing; also with Mitchell H. Katz, MD, chief executive officer of New York City Health and Hospitals and author of Modernize Medical Licensing, and Credentialing, Too—Lessons From the COVID-19 Pandemic

Coronavirus Vaccine Update With Arnold S. Monto, MD Jan 13, 2021

Show notes

Arnold S. Monto, MD, chaired the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings in December that led to Emergency Use Authorization (EUA) of the Pfizer/BioNTech and Moderna vaccines. He joins JAMA's Q&A series from the University of Michigan School of Public Health to discuss experience to date with the 2 products and what's next in vaccine development. Recorded January 11, 2021.

Related Article(s):

Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More

Using Lorenz Curves to Measure Racial Inequities in COVID-19 Testing Jan 12, 2021

Show notes

Aaloke Mody, MD, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study that uses Lorenz curves as a metric for quantifying racial inequities in coronavirus disease 2019 (COVID-19) testing. Read the article here: https://ja.ma/2MOMjWG.

JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

Understanding the New SARS-CoV-2 Mutation Found in England Jan 08, 2021

Show notes

Gregory Armstrong, MD, director of the Advanced Molecular Detection Program for the CDC, explains what is currently known about the new mutations of SARS-CoV-2.

Related Article(s):

Genetic Variants of SARS-CoV-2—What Do They Mean?

COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions Jan 06, 2021

Show notes

Tom Shimabukuro, MD, MPH, MBA, and Sara Mbaeyi, MD, MPH, from the CDC discuss rare allergic complications in patients who received the first dose of the Pfizer-BioNTech vaccine between December 14-23, 2020.

Understanding SARS-CoV-2 Genetic Variants Jan 06, 2021

Show notes

Adam Lauring, MD, PhD, from the University of Michigan Division of Infectious Diseases, an expert on the evolutionary biology of RNA viruses, explains the new genetic variants recently found in SARS-CoV-2 and their importance.

Related Article(s): Genetic Variants of SARS-CoV-2—What Do They Mean?

Public Concern About Violence, Firearms, and the COVID-19 Pandemic in California Jan 05, 2021

Show notes

Nicole Kravitz-Wirtz, PhD, MPH, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study describing individuals' concerns regarding violence in the context of the coronavirus disease 2019 (COVID-19) pandemic, experiences of pandemic-related unfair treatment, prevalence of and reasons for firearm acquisition, and changes in firearm storage practices due to the pandemic. Read the article here: https://ja.ma/2X7lC1x.

JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

Related Podcasts